Fallopian tube endometriosis

Summary

Fallopian tube endometriosis (MONDO:0001282) is a disease. A subtype of fallopian tube disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	fallopian tube endometriosis
Mondo ID	MONDO:0001282
DOID	DOID:11424
ICD-10-CM	N80.2
ICD-11	1506672895
NCIT	C26763
SNOMED CT	22611009
UMLS	C0014177
MedGen	41788
Anatomy (UBERON)	UBERON:0003889
Is cancer (heuristic)	no

Also known as: endometriosis (disease) of fallopian tube · endometriosis of fallopian tube · fallopian tube endometriosis · fallopian tube endometriosis (disease)

Disease family

This is a subtype of fallopian tube disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › reproductive system disorder › female reproductive system disorder › fallopian tube disorder › fallopian tube endometriosis

Related subtypes (5): salpingitis, fallopian tube neoplasm, embryonic cyst of fallopian tube, tubal pregnancy, hydrosalpinx

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.